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Professor's cancer research recognized in national journal  
Maggie Louie, associate professor in Dominican University of California’s Department of Natural Sciences 
and Mathematics, is co-author of a study published this week in the prestigious journal Nature Medicine.  
Louie worked alongside researchers at UC Davis, in collaboration with the other institutions, on studies 
examining the cause of prostate cancer. The researchers found that suppressing the nuclear receptor protein 
ROR-γ with small-molecule compounds can reduce androgen receptor (AR) levels in castration-resistant 
prostate cancer and stop tumor growth. 
 
According to a release issued by UC Davis, this novel approach does not directly target the AR, but rather 
inhibits the gene that codes for the AR protein. Reducing AR levels could help patients overcome 
treatment-resistant prostate cancer and even rescue existing therapies. 
 
In the vast majority of prostate cancers, according to the UC Davis release about the findings, the AR gene 
becomes hyperactive, driving tumor growth and metastasis. Anti-androgen therapies can slow, and even 
stop, prostate cancer -- for a time. But quite often the gene mutates to resist the treatment. 
 
However, suppressing ROR-γ circumvents this resistance. Because the protein is required for AR gene 
expression, ROR-γ inhibition strongly reduces AR protein levels in tumor cells. By preventing AR protein 
synthesis, ROR-γ antagonists can potentially short-circuit the resistance process. 
 
The research team was led by Hongwu Chen, a professor in the Department of Biochemistry and Molecular 
Medicine at UC Davis. 
 
Louie, who received her PhD from UC Davis, worked on this study during a recent sabbatical from 
Dominican’s Department of Natural Sciences and Mathematics. 
 
At Dominican, Louie’s National Institutes of Health funded research focuses on the role environmental 
contaminants play in breast cancer. Currently, Louie and her students are examining how oxidative stress 
impacts the development and progression of breast cancer cells. 
 
Louie has been studying how environmental contaminants promote cancer progression since joining 
Dominican’s faculty in 2005. Louie involves both her undergraduate and graduate students in her research. 
She and her team have received more than $1 million in grants from the NIH to fund their work. 
 
Earlier research, including previous work from the Louie lab in the School of Health and Natural Sciences, 
has shown that breast cancer cells become increasingly aggressive the longer they are exposed to small 
concentrations of cadmium, a common environmental contaminant that enters the body through 
consumption of contaminated food, water, or inhalation of cigarette smoke. 
 
Now Louie is investigating how long-term exposure to low levels of cadmium can trigger oxidative stress, 
a process that leads to cellular damage and potentially contribute to breast cancer development and 
progression. 
 
For more information about the Louie lab, please follow this link. 
 
For more information about the UC Davis study, please follow this link. 
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